Cargando…
Targeting TLR2/Rac1/cdc42/JNK Pathway to Reveal That Ruxolitinib Promotes Thrombocytopoiesis
Background: Thrombocytopenia has long been considered an important complication of chemotherapy and radiotherapy, which severely limits the effectiveness of cancer treatment and the overall survival of patients. However, clinical treatment options are extremely limited so far. Ruxolitinib is a poten...
Autores principales: | Yang, Shuo, Tang, Xiaoqin, Wang, Long, Ni, Chengyang, Wu, Yuesong, Zhou, Ling, Zeng, Yueying, Zhao, Chunling, Wu, Anguo, Wang, Qiaozhi, Xu, Xiyan, Wang, Yiwei, Chen, Rong, Zhang, Xiao, Zou, Lile, Huang, Xinwu, Wu, Jianming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787584/ https://www.ncbi.nlm.nih.gov/pubmed/36555781 http://dx.doi.org/10.3390/ijms232416137 |
Ejemplares similares
-
Zebrafish for thrombocytopoiesis- and hemostasis-related researches and disorders
por: Meng, Panpan, et al.
Publicado: (2020) -
TMEA, a Polyphenol in Sanguisorba officinalis, Promotes Thrombocytopoiesis by Upregulating PI3K/Akt Signaling
por: Li, Hong, et al.
Publicado: (2021) -
Role of β1 integrin in thrombocytopoiesis
por: Mazzarini, Maria, et al.
Publicado: (2021) -
The evolutionary history of effectors downstream of Cdc42 and Rac
por: Cotteret, Sophie, et al.
Publicado: (2002) -
Targeting Rac and Cdc42 GEFs in Metastatic Cancer
por: Maldonado, Maria del Mar, et al.
Publicado: (2020)